NCT04419181 2025-10-14Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast CancerUniversity of RochesterPhase 2 Withdrawn
NCT03709082 2024-03-05Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerUniversity of Kansas Medical CenterPhase 1/2 Terminated3 enrolled